Glaukos Corporation

NYSE:GKOS 4:00:00 PM EDT

126.90

-1.34 (-1.04%)

5:15:09 PM EDT: $126.42 -0.48 (-0.38%)

Market Cap (Intraday)	6.90B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$91.52 Million
Adjusted EPS	-$0.48

See more estimates

10-Day MA	$127.88
50-Day MA	$126.98
200-Day MA	$107.72

See more pivots

Glaukos Corporation Stock, NYSE:GKOS

229 Avenida Fabricante, One Glaukos Way, Aliso Viejo, California 92656

United States of America

Phone: +1.949.367.9600

Number of Employees: 907

http://www.glaukos.com

Description

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.